Similar Search Results

Health insurance and the growth in pharmaceutical expenditures

Danzon, Patricia Munch; Pauly, Mark V. - In: The journal of law & economics 45 (2002) 2,2, pp. 587-613

Persistent link: https://www.econbiz.de/10001780831

Information asymmetries and risk management in healthcare markets : the US affordable care act in retrospect

Mendoza, Roger Lee - In: Journal of economic issues : jei 51 (2017) 2, pp. 520-540

Persistent link: https://www.econbiz.de/10011787359

Outpatient prescription drug prices and insurance coverage : an analysis by therapeutic drug class and user characteristics from the 1996 Medical Expenditure Panel Survey

Miller, G. Edward; Moeller, John - In: Investing in health : the social and economic benefits …, (pp. 23-57). 2001

Persistent link: https://www.econbiz.de/10001640125

The effect of Medicare Part D on pharmaceutical prices and utilization

Duggan, Mark G.; Scott Morton, Fiona - In: The American economic review 100 (2010) 1, pp. 590-607

Persistent link: https://www.econbiz.de/10008732288

The medium-term impact of medicare Part D on pharmaceutical prices

Duggan, Mark G.; Scott Morton, Fiona - In: The American economic review 101 (2011) 3, pp. 387-392

Persistent link: https://www.econbiz.de/10009266609

Reference pricing for drugs : is it compatible with US health care?

Kanavos, Panos; Reinhardt, Uwe E. - In: Health affairs : at the intersection of health, health … 22 (2003) 3, pp. 16-30

Persistent link: https://www.econbiz.de/10001767920

The effect of Medicare part D on pharmaceutical prices and utilization

Duggan, Mark G.; Scott Morton, Fiona - 2008

region. This paper evaluates the effect of this program on the price and utilization of pharmaceutical treatments … potentially negotiate price discounts through their ability to influence the market share of specific treatments. Using data on … the average price and increased the total utilization of prescription drugs by Medicare recipients. Our results further …